Target intelligence / Profile preview

Intestinal Mucosal Barrier and Gut Microbiota

Molecular classification
Other
01

Overview

The intestinal flora and intestinal barrier represent a complex, integrated biological system essential for maintaining systemic homeostasis and protecting the host from luminal pathogens and toxins. The intestinal flora, or gut microbiota, consists of trillions of microorganisms that contribute to metabolic processes, vitamin synthesis, and the maturation of the host immune system (Frontiers in Cellular and Infection Microbiology, 2022). The intestinal barrier is a multi-layered structure comprising a chemical barrier (mucus and antimicrobial peptides), a physical barrier (epithelial cells and tight junctions), and an immunological barrier (gut-associated lymphoid tissue) (Nature Reviews Gastroenterology & Hepatology, 2017). Disruption of this system, often referred to as increased intestinal permeability or "leaky gut," is a key pathogenic factor in various systemic and localized inflammatory conditions, including inflammatory bowel disease (IBD), metabolic syndrome, and nonalcoholic fatty liver disease (NIH/PubMed). Therapeutic strategies targeting this system aim to restore microbial balance through probiotics or fecal transplants and strengthen barrier integrity via trophic factors like GLP-2 analogs or specific enzyme inhibitors (Journal of Gastroenterology and Hepatology, 2007).

Other names
Intestinal floraGut microbiomeIntestinal barrierIntestinal mucosal barrierLeaky gutIntestinal permeabilityGut-liver axis
02

Mechanism of action

Modulation of microbial composition and diversity, enhancement of tight junction protein expression (e.g., ZO-1, occludin), stimulation of mucus production by goblet cells, and regulation of mucosal immune responses such as secretory IgA production.

03

Biological functions

Immune responseMetabolismBarrier functionPathogen defenseNutrient absorptionVitamin synthesisSignal transduction
04

Disease associations

Inflammatory bowel diseaseIrritable bowel syndromeMetabolic syndromeObesityType 2 diabetesNonalcoholic fatty liver diseaseCardiovascular diseaseSepsisCeliac disease
05

Safety considerations

Risk of systemic infection (bacteremia) in immunocompromised patientsInduction of microbial dysbiosisTransfer of antibiotic resistance genesVariable patient response due to baseline microbiome diversityPotential for long-term metabolic or autoimmune disruptions
06

Interacting drugs

Teduglutide

9 more in the full profile.

07

Biomarkers

ZonulinCalprotectinDiamine oxidase (DAO)Intestinal fatty acid-binding protein (I-FABP)Claudin-3Lipopolysaccharide (LPS)LPS-binding protein (LBP)Lactulose/Mannitol ratio

Beyond the preview

Go deeper on Intestinal Mucosal Barrier and Gut Microbiota.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal Mucosal Barrier and Gut Microbiota.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call